129 related articles for article (PubMed ID: 19584572)
1. Acquisition-weighted MRSI for detection and quantification of BNCT 10B-carrier L-p-boronophenylalanine-fructose complex, a phantom study.
Timonen M; Kankaanranta L; Lundbom N; Kortesniemi M; Seppälä T; Kouri M; Savolainen S; Heikkinen S
J Radiat Res; 2009 Sep; 50(5):435-40. PubMed ID: 19584572
[TBL] [Abstract][Full Text] [Related]
2. 1H MRS of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T.
Heikkinen S; Kangasmäki A; Timonen M; Kankaanranta L; Häkkinen AM; Lundbom N; Vähätalo J; Savolainen S
Phys Med Biol; 2003 Apr; 48(8):1027-39. PubMed ID: 12741499
[TBL] [Abstract][Full Text] [Related]
3. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S
Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888
[TBL] [Abstract][Full Text] [Related]
4. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG
Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522
[TBL] [Abstract][Full Text] [Related]
5. Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields.
Porcari P; Capuani S; Campanella R; La Bella A; Migneco LM; Maraviglia B
Phys Med Biol; 2006 Jun; 51(12):3141-54. PubMed ID: 16757868
[TBL] [Abstract][Full Text] [Related]
6. T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy.
Yamamoto Y; Isobe T; Yamamoto T; Shibata Y; Anno I; Nakai K; Shirakawa M; Matsushita A; Sato E; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S345-7. PubMed ID: 19406648
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive quantitative in vivo mapping and metabolism of boronophenylalanine (BPA) by nuclear magnetic resonance (NMR) spectroscopy and imaging.
Bendel P; Margalit R; Koudinova N; Salomon Y
Radiat Res; 2005 Nov; 164(5):680-7. PubMed ID: 16238447
[TBL] [Abstract][Full Text] [Related]
8. Optimized 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine.
Bendel P; Margalit R; Salomon Y
Magn Reson Med; 2005 May; 53(5):1166-71. PubMed ID: 15844166
[TBL] [Abstract][Full Text] [Related]
9. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
[TBL] [Abstract][Full Text] [Related]
10. Capillary electrophoresis-electrospray mass spectrometry and HR-ICP-MS for the detection and quantification of 10B-boronophenylalanine (10B-BPA) used in boron neutron capture therapy.
Pitois A; de las Heras LA; Zampolli A; Menichetti L; Carlos R; Lazzerini G; Cionini L; Salvatori PA; Betti M
Anal Bioanal Chem; 2006 Feb; 384(3):751-60. PubMed ID: 16372182
[TBL] [Abstract][Full Text] [Related]
11. (10)B-NMR determination of (10)B-BPA, (10)B-BPA-fructose complex and total (10)B in blood for BNCT.
Yoshino K; Yabe T; Hattori T; Saito K; Ishikawa A; Ohki H
Appl Radiat Isot; 2014 Jun; 88():74-7. PubMed ID: 24530317
[TBL] [Abstract][Full Text] [Related]
12. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
[TBL] [Abstract][Full Text] [Related]
13. Studies on the structure of the complex of the boron neutron capture therapy drug, L-p-boronophenylalanine, with fructose and related carbohydrates: chemical and 13C NMR evidence for the beta-D-fructofuranose 2,3,6-(p-phenylalanylorthoboronate) structure.
Shull BK; Spielvogel DE; Head G; Gopalaswamy R; Sankar S; Devito K
J Pharm Sci; 2000 Feb; 89(2):215-22. PubMed ID: 10688750
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.
Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
Clin Cancer Res; 1998 Aug; 4(8):1833-41. PubMed ID: 9717809
[TBL] [Abstract][Full Text] [Related]
15. Quantitative bioimaging of p-boronophenylalanine in thin liver tissue sections as a tool for treatment planning in boron neutron capture therapy.
Reifschneider O; Schütz CL; Brochhausen C; Hampel G; Ross T; Sperling M; Karst U
Anal Bioanal Chem; 2015 Mar; 407(9):2365-71. PubMed ID: 25015045
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
18. Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): a comparison between 1H and 10B NMR.
Bendel P; Sauerwein W
Med Phys; 2001 Feb; 28(2):178-83. PubMed ID: 11243341
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
20. Inborn errors in metabolism and 4-boronophenylalanine-fructose-based boron neutron capture therapy.
Laakso J; Ruokonen I; Lapatto R; Kallio M
Radiat Res; 2003 Nov; 160(5):606-9. PubMed ID: 14565820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
